[1] Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics—2019 update: a report from the American Heart Association[J]. Circulation, 2019, 139(10): e56-e528.
[2] 张小贞, 王树伟, 刘洁, 等. 婴幼儿左向右分流型先天性心脏病合并重症肺炎的体外循环管理[J]. 国际心血管病杂志,2018,45(4):233-235.
[3] 朱瑞, 张成鑫, 李鑫, 等. 202例感染性心内膜炎患者临床特征及手术时机分析[J]. 国际心血管病杂志, 2018, 45(6):358-362.
[4] Pierpont ME, Brueckner M, Chung WK, et al. Genetic basis for congenital heart disease: revisited: a scientific statement from the American Heart Association[J]. Circulation, 2018, 138(21):e653-e711.
[5] Li YJ, Yang YQ. An update on the molecular diagnosis of congenital heart disease: focus on loss-of-function mutations[J]. Expert Rev Mol Diagn, 2017, 17(4):393-401.
[6] Al-Qattan MM, Abou Al-Shaar H. Molecular basis of the clinical features of Holt-Oram syndrome resulting from missense and extended protein mutations of the TBX5 gene as well as TBX5 intragenic duplications[J]. Gene, 2015, 560(2):129-136.
[7] Vanlerberghe C, Jourdain AS, Ghoumid J, et al. Holt-Oram syndrome: clinical and molecular description of 78 patients with TBX5 variants[J]. Eur J Hum Genet, 2019, 27(3): 360-368.
[8] Zhang XL, Qiu XB, Yuan F, et al. TBX5 loss-of-function mutation contributes to familial dilated cardiomyopathy[J]. Biochem Biophys Res Commun, 2015, 459(1):166-171.
[9] 董斌斌, 刘兴元, 杨奕清. 先天性心脏缺损相关 NR2F2 基因新突变研究[J]. 国际心血管病杂志, 2019, 46(4):240-243.
[10] Bruneau BG, Logan M, Davis N, et al. Chamber-specific cardiac expression of Tbx5 and heart defects in Holt-Oram syndrome[J]. Dev Biol, 1999, 211(1):100-108.
[11] Moskowitz IP, Pizard A, Patel VV, et al. The T-Box transcription factor Tbx5 is required for the patterning and maturation of the murine cardiac conduction system[J]. Development, 2004, 131(16):4107-4116.
[12] Bruneau BG, Nemer G, Schmitt JP, et al. A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease[J]. Cell, 2001, 106(6):709-721.
[13] Hatcher CJ, Goldstein MM, Mah CS, et al. Identification and localization of TBX5 transcription factor during human cardiac morphogenesis[J]. Dev Dyn, 2000, 219(1):90-95.
[14] Zhou W, Zhao L, Jiang JQ, et al. A novel TBX5 loss-of-function mutation associated with sporadic dilated cardiomyopathy[J]. Int J Mol Med, 2015, 36(1):282-288.
[15] Wang ZC, Ji WH, Ruan CW, et al. Prevalence and spectrum of TBX5 mutation in patients with lone atrial fibrillation[J]. Int J Med Sci, 2016, 13(1):60-67.
[16] Wang S, Zhang J, He X, et al. Identification and functional analysis of genetic variants in TBX5 gene promoter in patients with acute myocardial infarction[J]. BMC Cardiovasc Disord, 2019, 19(1):265.